Cure My Disease

Don't miss your cure!

 Log in / Sign up

New microwave probe aims to zap lung tumors without cutting

NCT ID NCT07291973

Recruiting now Disease control Sponsor: Endowave Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new device called the FlexAblate Microwave Ablation System that uses heat from microwaves to destroy small lung cancer nodules. It is for people who cannot have surgery or choose not to. The trial will check if the device safely and completely treats the tumor, with follow-up scans and tests over one year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Microwave ablation device (FlexAblate Microwave Transbronchial Ablation System)
What this could lead to
If successful, this could offer a less invasive treatment option for people with small lung cancer nodules who cannot have surgery.
What could go wrong
This is an early-stage study with only 43 participants, so results may not apply to everyone. The procedure carries risks like bleeding or infection, and it may not fully destroy the tumor.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • CMC Ambroise Paré - Hartmann

    RECRUITING

    Paris, France

  • St. Bartholomew's Hospital

    RECRUITING

    London, United Kingdom

  • University College London Hospitals NHS Foundation Trust

    RECRUITING

    London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.